Glenmark launches pain relief drug in US
News | 30 July 2010
NEW DELHI: Pharma major Glenmark Generics on Friday commenced marketing and distribution of Cyclobenzaprine Hydrochloride tablets in the US market. ...
Click on the link to read the full article at Hindu Business Line
(This link will open in a new window)
- Pfizer returns worldwide rights to Celldex Thera’s rindopepimut brain tumor vaccine candidate
- India’s Natco challenges Celgene’s Revlimid patent in USA; new CFO named
- Roche plans job cuts, announcing Operational Excellence initiative
- US FDA makes label change on Pfizer’s Tygacil to reflect increased mortality risk
- Weighted average drug price cuts of 20% for over 4,000 drugs enforced in Greece as of today
